ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $66,866,000 | 7.90% |
| RA Capital Management | 3,000,000 | $29,940,000 | 3.54% |
| Camber Capital Management LP | 3,250,000 | $32,435,000 | 3.05% |
| DOHENY ASSET MANAGEMENT /CA | 542,325 | $5,412,000 | 2.71% |
| QVT Financial LP | 2,504,677 | $24,997,000 | 1.29% |
| Atika Capital Management LLC | 123,700 | $1,235,000 | 0.95% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,996,000 | 0.58% |
| Bain Capital Public Equity Management, LLC | 2,246,632 | $22,421,000 | 0.58% |
| BB BIOTECH AG | 1,279,340 | $12,768,000 | 0.52% |
| EAM Investors, LLC | 222,842 | $2,224,000 | 0.45% |